Xvivo Perfusion AB (publ) (LON:0RKL)

London flag London · Delayed Price · Currency is GBP · Price in SEK
284.49
+2.29 (0.81%)
At close: Jun 27, 2025
-32.10%
Market Cap 683.75M
Revenue (ttm) 65.93M
Net Income (ttm) 10.56M
Shares Out n/a
EPS (ttm) 0.33
PE Ratio 64.73
Forward PE 43.24
Dividend n/a
Ex-Dividend Date n/a
Volume 1,213
Average Volume 2,689
Open 284.00
Previous Close 282.20
Day's Range 281.40 - 291.40
52-Week Range 245.00 - 545.00
Beta 1.93
RSI 41.76
Earnings Date Jul 11, 2025

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1998
Employees 190
Stock Exchange London Stock Exchange
Ticker Symbol 0RKL
Full Company Profile

Financial Performance

In 2024, Xvivo Perfusion AB's revenue was 822.42 million, an increase of 37.63% compared to the previous year's 597.54 million. Earnings were 172.18 million, an increase of 87.52%.

Financial numbers in SEK Financial Statements

News

There is no news available yet.